C30H34N8
506.6 g/mol
医药原料药警告
Bemcentinib
CAS1037624-75-1
用途分类
医药原料药
化合物类别
胺
主要用途
医药原料
Bemcentinib is an experimental oral small molecule that acts as an inhibitor of AXL kinase. It is being investigated in Phase II clinical trials for various solid and hematological tumors, both as monotherapy and in combination with other treatments.
research compound for AXL kinase inhibition studiespharmaceutical raw material for oncology research
内容范围: 本页信息面向化学品识别与工业供应、研发、生产场景，不构成疗效宣称、医疗建议或药品使用指导。
正在采购或供应此化合物？
发布库存产品或采购需求
CAS 1037624-75-1
相关化合物
安全参考
警告
H302Harmful if swallowed
标识符
IUPAC 名称
1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine
InChIKey
KXMZDGSRSGHMMK-VWLOTQADSA-N
SMILES
C1CCN(C1)[C@H]2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76
别名列表 (23)
- R428
- W-5845
- Bemcentinib (USAN/INN)
- AXL Inhibitor BGB324
- BGB 324; R 428
- Bemcentinib
- Bemcentinib (GMP)
- Bemcentinib (R428)
- BemcentinibR428BGB324)
- R-428 compound
- R428 (BGB324)
- bemcentinibum